Brii Biosciences Sets 20 August 2026 Board Meeting to Review 1H26 Interim Results
Bulletin Express
Aug 07
On 7 August 2026, Brii Biosciences Limited announced that its board of directors will convene on Thursday, 20 August 2026. The agenda includes consideration and approval of the unaudited interim results for the six-month period ended 30 June 2026, along with other routine matters.
As of the announcement date, the board comprises Executive Directors Dr. Zhi Hong and Dr. Ankang Li, and Independent Non-Executive Directors Dr. Martin J. Murphy Jr., Ms. Grace Hui Tang, Mr. Yiu Wa Alec Tsui, Mr. Gregg Huber Alton and Dr. Taiyin Yang.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.